“Baricitinib Achieved Complete Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 1, Jan. 2025, p. s520, https://doi.org/10.25251/skin.9.supp.520.